1. Home
  2. WST vs EL Comparison

WST vs EL Comparison

Compare WST & EL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • EL
  • Stock Information
  • Founded
  • WST 1923
  • EL 1946
  • Country
  • WST United States
  • EL United States
  • Employees
  • WST N/A
  • EL N/A
  • Industry
  • WST Medical/Dental Instruments
  • EL Package Goods/Cosmetics
  • Sector
  • WST Health Care
  • EL Consumer Discretionary
  • Exchange
  • WST Nasdaq
  • EL Nasdaq
  • Market Cap
  • WST 18.0B
  • EL 34.9B
  • IPO Year
  • WST N/A
  • EL 1995
  • Fundamental
  • Price
  • WST $279.15
  • EL $98.76
  • Analyst Decision
  • WST Strong Buy
  • EL Buy
  • Analyst Count
  • WST 8
  • EL 20
  • Target Price
  • WST $333.71
  • EL $90.95
  • AVG Volume (30 Days)
  • WST 619.1K
  • EL 3.4M
  • Earning Date
  • WST 10-23-2025
  • EL 10-30-2025
  • Dividend Yield
  • WST 0.32%
  • EL 1.42%
  • EPS Growth
  • WST N/A
  • EL N/A
  • EPS
  • WST 6.68
  • EL N/A
  • Revenue
  • WST $2,960,200,000.00
  • EL $14,326,000,000.00
  • Revenue This Year
  • WST $6.28
  • EL $6.11
  • Revenue Next Year
  • WST $6.11
  • EL $4.22
  • P/E Ratio
  • WST $41.80
  • EL N/A
  • Revenue Growth
  • WST 2.90
  • EL N/A
  • 52 Week Low
  • WST $187.43
  • EL $48.37
  • 52 Week High
  • WST $352.33
  • EL $104.53
  • Technical
  • Relative Strength Index (RSI)
  • WST 70.44
  • EL 58.69
  • Support Level
  • WST $260.12
  • EL $91.10
  • Resistance Level
  • WST $265.66
  • EL $104.53
  • Average True Range (ATR)
  • WST 5.42
  • EL 3.53
  • MACD
  • WST 1.11
  • EL 0.86
  • Stochastic Oscillator
  • WST 100.00
  • EL 66.46

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About EL Estee Lauder Companies Inc. (The)

Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%), with top-selling brands such as Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.

Share on Social Networks: